Daniel Newman, CEO, Futurum Group, breaks down what investors should watch for ahead of next week's big tech earnings.

The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".

First Financial Bancorp. (NASDAQ:FFBC ) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET Company Participants Archie M.

Camden's Q2 results may show stable occupancy and revenue gains, but FFO per share is expected to have declined slightly.

Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million) Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million)

Dorman Products' recent financials show revenue and profit growth, but the stock remains fairly valued versus peers, justifying my continued "Hold" rating. Management expects moderate growth for 2025, but economic uncertainty and tariff risks keep me cautious about upgrading my outlook. The company is making progress on debt reduction and operational efficiency, yet capital allocation could be improved for shareholder value.

Amazon (NASDAQ:AMZN) is one of Jim Cramer's favorite stocks.

Southern Missouri Bancorp, Inc. (NASDAQ:SMBC ) Q4 2025 Earnings Conference Call July 24, 2025 10:30 AM ET Company Participants Greg A. Steffens - Chairman & CEO Matthew T.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sarepta To Contact Him Directly To Discuss Their Options

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday.

AutoNation, Inc. (NYSE:AN ) Q2 2025 Earnings Conference Call July 25, 2025 9:00 AM ET Company Participants Derek Fiebig - Vice President of Investor Relations Michael M. Manley - CEO & Director Thomas A.

BG's Q2 performance is expected to have been weak, with earnings declining 31% y/y and sales falling 14% amid weaker agribusiness volumes and margins.

American Eagle is flashing a technical buy signal, supported by a double bottom, bullish volume patterns, and a possible short squeeze setup. Valuation metrics are compelling with shares trading near book value and a forward P/E under 10x, with attractive free cash flow and dividend yields. Sydney Sweeney's celebrity campaign could spark sales momentum, creating swarms of retail-investor buying and forcing shorts to cover, amplifying upside potential in the stock.

Unisys and DXC Technology are two legacy IT service firms undergoing critical transformations to stay competitive in an AI and cloud-driven era.

Investors need to pay close attention to Cenovus Energy stock based on the movements in the options market lately.

Charter Communications, Inc. (NASDAQ:CHTR ) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET Company Participants Christopher L. Winfrey - President, CEO & Director Jessica M.

Betterware de México, S.A.P.I. de C.V. delivered year-over-year revenue and EBITDA growth of 5.1% and 3.5%, respectively, in Q2. Jafra Mexico posted Q2 revenue growth of 10.9%, with corresponding EBITDA growth of 14.2%, now accounting for close to 60% of overall EBITDA. Management's guidance points to a growth acceleration in total revenue for the second half, coupled with expanding margins.

Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million) Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million)

CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today announced it is introducing ‘AI nutrition labels' to provide clear, concise information about how artificial intelligence (AI) is used across its safety and security technologies. The initiative is a first for public safety and enterprise security products, helping people understand a product's core AI “ingredients,” just as food nutrition labels were born from a desire to understand dietary intake. “It is our unwavering conviction.

Despite a greedy market, we've found three quality stocks - NVO, RGA, and CP - offering strong value, growth, and reliable dividends. Novo Nordisk leads obesity treatment with strong GLP-1 drugs, a robust pipeline, and a 3.1% yield, trading well below historical P/E. Reinsurance Group of America is an undervalued, financially sound dividend grower with global reach and double-digit earnings growth potential.